K Number
K211016

Validate with FDA (Live)

Manufacturer
Date Cleared
2022-06-29

(450 days)

Product Code
Regulation Number
884.5160
Reference & Predicate Devices
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The Powered Breast Pump (Models 7V and 7X) is a single-user, powered breast pump intended to express and collect milk from the breasts of lactating women.

Device Description

The Powered Breast Pump (Models 7V and 7X) is a powered breast pump that is intended to express and collect milk from the breasts of lactating women. The device is intended for a single user and can be used in home and professional healthcare environments.

The subject device can be used for single or double breast pumping and consists of the following key components: a motor unit with a press-button user interface, expression kits (NexusFit™ Cap, Diaphragm, Pump Body, Breast Shield, and Valve; areola shield; milk collection kit), and a silicone vacuum tube.

The Powered Breast Pump (Models 7V and 7X) has two operational modes (massage and expression), with user-selectable vacuum and cycle levels in each mode (levels are shown in Section 7 of the summary). Both device models are powered by an external AC power supply, while all 7V and select 7X models can be operated using an internal rechargeable lithium-ion battery. The device is provided nonsterile.

All milk contacting components are compliant with 21 CFR 174-179

AI/ML Overview

The provided document is a 510(k) summary for a Powered Breast Pump (Models 7V and 7X). It does not contain information about the acceptance criteria and study proving device meets acceptance criteria in the context of an AI/ML powered medical device. The document is for a physical medical device and discusses electrical safety, electromagnetic compatibility, software evaluation based on the 2005 FDA guidance (not specific to AI/ML), and physical performance testing such as vacuum level verification and use-life testing.

Therefore, I cannot extract the requested information regarding acceptance criteria and studies for an AI/ML powered device from this document.

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo is in blue and includes the letters "FDA" in a square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION".

June 29, 2022

Haenim Co., Ltd. % Priscilla Chung Regulatory Affairs Consultant LK Consulting Group USA, Inc. 1150 Roosevelt. STE 200 Irvine, CA 92620

Re: K211016

Trade/Device Name: Powered Breast Pump (Models 7V and 7X) Regulation Number: 21 CFR§ 884.5160 Regulation Name: Powered Breast Pump Regulatory Class: II Product Code: HGX Dated: Mav 25, 2022 Received: May 31, 2022

Dear Priscilla Chung:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.

{1}------------------------------------------------

You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatoryinformation/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

For Monica D. Garcia, Ph.D. Assistant Director DHT3B: Division of Reproductive, Gynecology and Urology Devices OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K211016

Device Name Powered Breast Pump (Models 7V and 7X)

Indications for Use (Describe)

The Powered Breast Pump (Models 7V and 7X) is a single-user, powered breast pump intended to express and collect milk from the breasts of lactating women.

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

510(k) Summary K211016

Date: June 28, 2022

1. Applicant / Submitter:

Applicant:Haenim Co., Ltd.
Address:15, Saryeom-ro 21beon-gil, Seo-gu, IncheonSouth Korea, 22742
Contact:Dae Won Kim
Tel:+82-32-324-6614

Submission Correspondent: 2.

Contact:Priscilla Chung
Address:LK Consulting Group USA, Inc.1150 Roosevelt STE 200,Irvine CA 92620
Phone:714-202-5789
Fax:714-409-3357
Email:juhee.c@lkconsultinggroup.com

3. Subject Device:

Proprietary Name:Powered Breast Pump (Models 7V and 7X)
Common Name:Powered breast pump
Regulation Name:Powered breast pump
Regulation Number21 CFR 884.5160
Product Code:HGX (pump, breast, powered)
Regulatory Class:Class II

Predicate Device: 4.

Proprietary Name:Hi bebesuper (Models BT-150S and BT-150L)
510(k) Number:K200675

The predicate device has not been subject to a design-related recall.

Device Description: 5.

The Powered Breast Pump (Models 7V and 7X) is a powered breast pump that is intended to express and collect milk from the breasts of lactating women. The device is intended for a single user and can be used in home and professional healthcare environments.

The subject device can be used for single or double breast pumping and consists of the following key components: a motor unit with a press-button user interface, expression kits (NexusFit™ Cap,

{4}------------------------------------------------

Diaphragm, Pump Body, Breast Shield, and Valve; areola shield; milk collection kit), and a silicone vacuum tube.

The Powered Breast Pump (Models 7V and 7X) has two operational modes (massage and expression), with user-selectable vacuum and cycle levels in each mode (levels are shown in Section 7 of the summary). Both device models are powered by an external AC power supply, while all 7V and select 7X models can be operated using an internal rechargeable lithium-ion battery. The device is provided nonsterile.

All milk contacting components are compliant with 21 CFR 174-179

6. Indications for Use:

The Powered Breast Pump (Models 7V and 7X) is a single-user, powered breast pump intended to express and collect milk from the breasts of lactating women.

Comparison of Intended Use and Technological Characteristics with the 7. Predicate Device

The table below compares the intended use and technological characteristics of the subject and predicate device.

Powered Breast Pump (Models 7Vand 7X)K211016Hi bebesuper (Models BT-150S andBT-150L)K200675Comparison
ManufacturerHaenim Co., Ltd.Bistos Co., Ltd.
Indications for UseThe Powered Breast Pump (7V and7X) is a single-user, powered breastpump intended to express and collectmilk from the breasts of lactatingwomen.Hi bebesuper (Models BT-150S andBT-150L) is intended to be used bylactating women for expressing andcollecting breast milk. It is intendedfor a single user.The subject andpredicate deviceindications for usestatements are notidentical; however,their intended usesare the same (i.e.,for collection ofmilk from thebreasts of lactatingwomen).
Pump OptionsSingle or DoubleSingle or DoubleSame
Suction ModesMassage Mode and Expression ModeMassage Mode and Expression ModeSame
Pump TypeDiaphragmUnknownDifferent: Thepump type of thepredicate device isnot known;however,differences in thepump type do notraise different
questions of safetyand effectiveness.
VisualIndicatorLED-light displayLiquid-crystal displayDifferent: Thesubject andpredicate deviceshave differentdisplay types.Differences invisual indicators donot raise differentquestions of safetyand effectiveness.
User ControlPowerPowerSame
MemoryLamp brightnessMode changeDecrease vacuumIncrease vacuumDecrease speedIncrease speedMemoryLamp brightnessMode changeDecrease vacuumIncrease vacuumDecrease speedIncrease speed
AccessoriesNexusFitTM Breast ShieldAreola shield 21mmBottle StandNexusFitTM CapNexusFitTM Pump BodyNexusFitTM DiaphragmNexusFitTM ValveTubingNippleBottle DiskBottle CapBottleDual ConnectorAdaptorFunnel (21/24/27/32 mm)Funnel Block Funnel capDiaphragm Top, Diaphragm andDiaphragm BottomAir tube and air tube connectorNippleBottleBottle capBottle cover and bottle discDifferent: Thesubject device hasdifferent packagedcomponents thanthe predicatedevice. Differencesin devicecomponents do notraise differentquestions of safetyand effectiveness.
Power7V:1. ACAdaptor inputAC100~240V50/60HzAdaptor outputDC5V 2.0A2. BatteryLi-ion 3.7V2600mAh7X:1.ACAdaptor inputAC100~240V50/60HzAdaptor outputDC12V 2.0A2. BatteryLi-ion 7.4V2200mAhBattery power only:7.4V Li-ion Polymer 2200 mADifferent: Thesubject deviceoperates under bothAC and batterypower, while thepredicate is onlybattery powered.Differences inpower supply donot raise differentquestions of safetyand effectiveness.
MaximumVacuumPressure-290 mmHg-290 mmHgSame
Cycle Speed7VExpressionMode: 30-50cycle/min7XExpressionMode: 34-55cycle/minExpression Mode: 35/40/45/50/55/60Cycle/Min.Massage Mode: 70/80/90 Cycle/MinDifferent: Thedifferences inspecifications donot raise different
Massage Mode:70-90 cycle/minExpressionMode: 5 levelsMassage Mode:70-105 cycle/minExpressionMode: 6 levelsExpression Mode: 6 levelsMassage Mode: 3 levelsquestions of safetyand effectiveness.
Massage Mode: 5 levelsMassage Mode: 5 levels
Vacuum Range(mmHg)7VSingle pumping:Massage mode: -50 to -120 mmHg ±20%Expression mode: -50 to -250 mmHg ± 20%Double pumping:Massage mode: -30 to -70 mmHg ±20%Expression mode: -40 to -180 mmHg ± 20%Single pumping:Massage mode: -50 to -140 mmHg ±20% Expression mode: -50 to -250mmHg ± 20%Double pumping:Massage mode: -30 to -80 mmHg ±20%Expression mode: -40 to -190 mmHg ± 20%Single pumping:Massage mode: -50 to -230 mmHg ±20%Expression mode: -50 to -250 mmHg ± 20%Double pumping:Massage mode: -30 to -150 mmHg ±20%Expression mode: -30 to -200 mmHg ± 20%Different: Thedifferences inspecifications donot raise differentquestions of safetyand effectiveness.
AdjustableVacuumLevels7V12 levels7X15 levels16 levelsDifferent: Thedifference in thenumber of suctionlevels do not raisedifferent questionsof safety andeffectiveness.
BackflowProtectionDiaphragm construction acts as amedia separation and prevents milkfrom going into the pump in case of amilk overflow into the vacuum tubes.Diaphragm construction acts as amedia separation and prevents milkfrom going into the pump in case of amilk overflow into the vacuum tubes.Same
Nursing NightLampYesOnly applicable to BT-150LDifferent:Differences indevice versionswith and withoutnursing night lampsdo not raisedifferent questionsof safety andeffectiveness.

{5}------------------------------------------------

{6}------------------------------------------------

{7}------------------------------------------------

The subject and predicate device do not have identical indications for use statements; however, they do have the same intended use, i.e., for collection of breast milk from the breasts of lactating women.

The subject and predicate device have different technological features, including the user interface, pump, vacuum range, cycle speed/range, and power sources. These technological differences do not raise different questions of safety and effectiveness.

Summary of Non-Clinical Performance Testing 8.

Biocompatibility

Biocompatibility testing was performed in accordance with the 2020 FDA guidance Use of International Standard ISO 10993-1, "Biological Evaluation of Medical Devices - Part 1: Evaluation and testing within a risk management process." Testing included the following:

  • Cytotoxicity (ISO 10993-5:2009) ●
  • . Sensitization (ISO 10993-10:2010)
  • . Irritation (ISO 10993-10:2010)

The testing supports the biocompatibility of the patient-contacting device materials that were shown to be non-cytotoxic, non-irritating, and non-sensitizing.

Electrical Safety

Testing was conducted in accordance with:

  • AAMI ANSI ES60601-1:2005/(R)2012 and A1:2012, Medical electrical equipment Part 1: ● General requirements for basic safety and essential performance (IEC 60601-1:2005, MOD)
  • · IEC 60601-1-11:2015. Medical electrical equipment Part 1-11: General requirements for basic safety and essential performance - Collateral Standard: Requirements for medical electrical equipment and medical electrical systems used in the home healthcare environment.
  • IEC 62133-2:2017, Secondary cells and batteries containing alkaline or other non-acid . electrolytes - Safety requirements for portable sealed secondary cells, and for batteries made from them, for use in portable applications - Part 2: Lithium systems

Electromagnetic Compatibility

Testing was conducted in accordance with IEC 60601-1-2:2014 Medical Electrical Equipment - Part 1-2: General Requirements For Basic Safety And Essential Performance - Collateral Standard: Electromagnetic Compatibility - Requirements And Tests

Software

Software was evaluated in accordance with the 2005 FDA guidance document Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices.

Performance Testing

{8}------------------------------------------------

Performance testing was conducted to demonstrate pump performance met established specifications in the following areas:

  • Vacuum level verification testing at each mode/cycle demonstrated that the devices meet mode/cycle specifications.
  • Backflow protection testing was conducted to verify liquid does not backflow into the tubing. ●
  • . Use-life testing was conducted to demonstrate that the device maintains its specifications throughout its proposed use-life.
  • . Battery performance testing was conducted to demonstrate that the battery remains functional during its stated battery use-life.
  • . Battery status indicator testing was conducted to demonstrate that the battery status indicator remains functional during its stated battery life.
  • . Battery charging testing to demonstrate the duration of time needed to fully recharge the battery.

Conclusion 9.

The performance testing described above demonstrates that the subject devices are as safe and effective as the predicate device and support a determination of substantial equivalence.

§ 884.5160 Powered breast pump.

(a)
Identification. A powered breast pump in an electrically powered suction device used to express milk from the breast.(b)
Classification. Class II (performance standards).